Advanced search
Publication Cover
Current Medical Research and Opinion Volume 4, 1977 - Issue 10
Submit an article Journal homepage
38
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Human studies on the bioavailability of a quaternary ammonium compound, tiemonium iodide and tiemonium methosulphate

I. T. Scoular Department of Clinical Pharmacology, St. Batholomew's Hospital, London, England; Pharmaceutical Division, Reckitt and Colman Ltd., Dansom Lane Hull, HU8 7DS, England
,
Anne Monks Department of Clinical Pharmacology, St. Batholomew's Hospital, London, England
,
C. Burgess Department of Clinical Pharmacology, St. Batholomew's Hospital, London, England
&
P. Turner Department of Clinical Pharmacology, St. Batholomew's Hospital, London, England
Pages 732-738 | Received 02 May 1977, Published online: 07 Aug 2008

References

  • Beau P. g., Constantin M., Talvard J., Duchene-Marullaz P. Elimination de l'iodure de tiémonium radioactif et essai de recherche des métabolites, chez le rat et la souris. Therapie 1968; 23: 399–4091. Beau P. g., Constantin M., Talvard J., Duchene-Marullaz P. Elimination de l'iodure de tiémonium radioactif et essai de recherche des métabolites, chez le rat et la souris. Therapie 1968; 23: 399–409
  • Beerman B., Hellström K., Rosen A. The gastro-intestinal absorption of anti-cholinergic drugs: comparison between individuals. Acta Pharmacol. Toxicol Kbh 1971; 29: 98–1022. Beerman B., Hellström K., Rosen A. The gastro-intestinal absorption of anti-cholinergic drugs: comparison between individuals. Acta Pharmacol. Toxicol Kbh 1971; 29: 98–102
  • Hellström K., Rosen A., Söderlund K. The gastro-intestinal absorption and the excretion of H3-butylscopolamine (hyoscine butylbromide) in man. Scand. J. Gastroenterol 1970; 5: 585–5923. Hellström K., Rosen A., Söderlund K. The gastro-intestinal absorption and the excretion of H3-butylscopolamine (hyoscine butylbromide) in man. Scand. J. Gastroenterol 1970; 5: 585–592
  • Herxheimer A., Haefeli L. Human pharmacology of hyoscine butylbromide. Lancet 1966; 2: 418–4214. Herxheimer A., Haefeli L. Human pharmacology of hyoscine butylbromide. Lancet 1966; 2: 418–421
  • Levine R. M., Clark B. B. The biotransformation, excretion and distribution of the anticholinergic quaternary ammonium compound benzomethamine (MC 3199) and its tertiary amine analog (MC 3137) and related compounds in animals. J. Pharmacol. Exp. Ther 1955; 114: 63–775. Levine R. M., Clark B. B. The biotransformation, excretion and distribution of the anticholinergic quaternary ammonium compound benzomethamine (MC 3199) and its tertiary amine analog (MC 3137) and related compounds in animals. J. Pharmacol. Exp. Ther 1955; 114: 63–77
  • Möller J., Rosen A. Comparative studies on parenteral and oral effective doses of anticholinergic drugs. Acta Med. Scand 1968; 184: 201–2096. Möller J., Rosen A. Comparative studies on parenteral and oral effective doses of anticholinergic drugs. Acta Med. Scand 1968; 184: 201–209
  • Pentikainen P., Penttilä A., Vapaatalo H., Hackman R. Intestinal absorption, intestinal distribution and excretion of (14C) labelled hyoscine N-butylbromide (butylscopolamine) in the rat. J. Pharm. Pharmacol 1973; 25: 371–3757. Pentikainen P., Penttilä A., Vapaatalo H., Hackman R. Intestinal absorption, intestinal distribution and excretion of (14C) labelled hyoscine N-butylbromide (butylscopolamine) in the rat. J. Pharm. Pharmacol 1973; 25: 371–375
  • Shand D. g., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin. Pharmacol. Ther 1970; 11: 112–1208. Shand D. g., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin. Pharmacol. Ther 1970; 11: 112–120
  • Vapaatalo H., Pentillä A., Kaltiala A. The absorption and elimination of orally administered (14C) hyoscine N-butylbromide (butylscopolamine). J. Pharm. Pharmacol 1975; 27: 542–5439. Vapaatalo H., Pentillä A., Kaltiala A. The absorption and elimination of orally administered (14C) hyoscine N-butylbromide (butylscopolamine). J. Pharm. Pharmacol 1975; 27: 542–543

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.